dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and Neoplasm Metastasis

dansylarginine n-(3-ethyl-1,5-pentanediyl)amide has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambrogio, C; Gasic, G; Karpatkin, S; Pearlstein, E	1

Other Studies

1 other study(ies) available for dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and Neoplasm Metastasis

Article	Year
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide. Progress in clinical and biological research, 1982, Volume: 89 Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Cell Transformation, Viral; Colonic Neoplasms; Complement Inactivator Proteins; Dansyl Compounds; Humans; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Platelet Aggregation; Rabbits; Simian virus 40	1982

Article

Year

Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.

Progress in clinical and biological research, 1982, Volume: 89

Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Cell Transformation, Viral; Colonic Neoplasms; Complement Inactivator Proteins; Dansyl Compounds; Humans; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Platelet Aggregation; Rabbits; Simian virus 40

1982